Fair Value Calculator Fair Value Calculator
EN DE

0827 (0827) Fair Value & Analysis

Basic Materials · Market cap HK$387M

0 0827 0827 · HK
PriceHK$0.0550
Fair ValueHK$0.1183
Upside+115.0%
Quality48/100
Evidence: Medium Range HK$0.0908 – HK$0.1513

Fair value as of: Jul 2, 2026

From 9 valuation models · updated today

Share price +71.9% over the past month.

Price vs Fair Value (12 months)

HK$0.0790 HK$0.0230 Fair Value HK$0.1183 Jun 2025 Jun 2026

12‑month range HK$0.0230 – HK$0.0790 · fair‑value band HK$0.0908 – HK$0.1513 · the HK$0.0550 price screens below the HK$0.1183 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

0827 (0827) currently trades at HK$0.0550, while our model-based Fair Value estimate is HK$0.1183 — implying the stock looks roughly 115.0% undervalued today. We read business quality at 48/100 (below-average quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

Over the trailing twelve months, 0827 generated revenue of HK$2.2B at a net margin of -34.6%. Revenue declined 19.5% year over year. Net debt stands at HK$2.8B. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$2.2B
Revenue growth (YoY) -19.5%
Net margin -34.6%
Return on equity -3,966%
Free cash flow HK$63.2M FY2025
Operating margin -40.4%
More key figures
EPS (TTM) HK$-0.0300
EPS growth (YoY) -36.4%
Net debt HK$2.8B FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

0827 reported revenue of HK$2.2B in FY2025 versus HK$3.1B in FY2021, a compound −8.4%/yr. Reported net income was −HK$747M in FY2025.

Revenue −8.4%/yr
FY21 HK$3.1B
FY22 HK$3.2B
FY23 HK$2.9B
FY24 HK$2.6B
FY25 HK$2.2B
Net income
FY21 HK$379M
FY22 HK$202M
FY23 −HK$152M
FY24 −HK$505M
FY25 −HK$747M

Is 0827 fairly valued? → Check now

Similar stocks

6 more Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock Price Fair Value vs Fair Value
Linde plc LIN €448.00 €191.66 -57%
Shin-Etsu Chemical Co SHECY $22.77 $13.22 -42%
BASF SE BAS €50.82 €9.45 -81%
Ningxia Baofeng Energy Group 600989 ¥22.46 ¥37.07 +65%
Dow Inc D1OW34 R$43.91 R$31.57 -28%
Ganfeng Lithium Group 002460 ¥65.65 ¥18.75 -71%

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is 0827 (0827) undervalued?
As of Jul 2, 2026, our model estimates a fair value of HK$0.1183 versus a price of HK$0.0550 — about +115% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 0827?
Our model-based fair value for 0827 is HK$0.1183 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.0550.
What is the quality score of 0827?
0827 has a Quality Score of 48/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of 0827 (0827)?
0827 reported trailing-twelve-month revenue of about HK$2.2B (latest available figure, as of Jul 2, 2026).
What is the net profit margin of 0827?
The net profit margin of 0827 is about -34.6%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.